EPIX ESSA Pharma
- 1.700
- +0.070+4.29%
- 1.680
- -0.020-1.18%
ESSA Pharma News
ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-10% Owner BIOTECH GROWTH N V
ESSA Pharma | 8-K: Current report
ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Virsik Peter
ESSA Pharma | 8-K: Current report
ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Virsik Peter
ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Virsik Peter
ESSA Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144
ESSA Pharma | 8-K: ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2024
ESSA Pharma | 10-Q: Q3 2024 Earnings Report
ESSA Pharma | 8-K: ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024
ESSA Pharma | 10-Q: Q2 2024 Earnings Report
ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Virsik Peter
ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Director Glickman Richard M
ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Virsik Peter
ESSA Pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
ESSA Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144
ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Director ZWEIFACH SANFORD S
ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Director Thorell Marella
ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Director Sollis Gary
ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Director Requadt Scott
Analysis
Price Target
No Data
No Data
